Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and deliveri ... ng life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit neurocrine.com. (*in collaboration with AbbVie) Neurocrine Biosciences was named to the FORTUNE Best Small & Medium Workplaces™ 2021 list, ranking No. 7 out of 100 medium-sized companies across the country. From FORTUNE. © 2021 FORTUNE Media IP Limited. All rights reserved. Used under license. read more